Cellular heterogeneity and drug resistance in two ovarian adenocarcinoma cell lines derived from a single patient

C. Roland Wolf, Ian P. Hayward, Sandra S. Lawrie, Karin Buckton, Margaret A. McIntyre, David J. Adams, Alexander D. Lewis, Angela R.R. Scott, John F. Smyth

Research output: Contribution to journalArticle

120 Citations (Scopus)

Abstract

Two ovarian cell lines were derived from the ascites of a patient before and after the onset of resistance to chemotherapy involving cis‐platinum, chlorambucil and 5‐fluorouracil. Characterization of these lines shows them to have various features in common and some significant differences. Cytologically the lines cannot be distinguished and they both contain high concentrations of oestrogen receptor. However, they do differ with respect to their growth characteristics, karyotype, glutathione content and sensitivity to cis‐platinum. The karyotypes of the 2 lines show several marker chromosomes in common but the resistant line contained a chromosome 8 and a 17 which were absent from the earlier sensitive line. This suggests a clonal origin with subsequent divergence to a heterogeneous population.

Original languageEnglish
Pages (from-to)695-702
Number of pages8
JournalInternational Journal of Cancer
Volume39
Issue number6
DOIs
Publication statusPublished - 15 Jun 1987

Fingerprint

Karyotype
Drug Resistance
Adenocarcinoma
Chlorambucil
Cell Line
Chromosomes, Human, Pair 8
Genetic Markers
Ascites
Estrogen Receptors
Glutathione
Drug Therapy
Growth
Population

Cite this

Wolf, C. Roland ; Hayward, Ian P. ; Lawrie, Sandra S. ; Buckton, Karin ; McIntyre, Margaret A. ; Adams, David J. ; Lewis, Alexander D. ; Scott, Angela R.R. ; Smyth, John F. / Cellular heterogeneity and drug resistance in two ovarian adenocarcinoma cell lines derived from a single patient. In: International Journal of Cancer. 1987 ; Vol. 39, No. 6. pp. 695-702.
@article{3e2638ba87a645f6859b9bdbfd6726bf,
title = "Cellular heterogeneity and drug resistance in two ovarian adenocarcinoma cell lines derived from a single patient",
abstract = "Two ovarian cell lines were derived from the ascites of a patient before and after the onset of resistance to chemotherapy involving cis‐platinum, chlorambucil and 5‐fluorouracil. Characterization of these lines shows them to have various features in common and some significant differences. Cytologically the lines cannot be distinguished and they both contain high concentrations of oestrogen receptor. However, they do differ with respect to their growth characteristics, karyotype, glutathione content and sensitivity to cis‐platinum. The karyotypes of the 2 lines show several marker chromosomes in common but the resistant line contained a chromosome 8 and a 17 which were absent from the earlier sensitive line. This suggests a clonal origin with subsequent divergence to a heterogeneous population.",
author = "Wolf, {C. Roland} and Hayward, {Ian P.} and Lawrie, {Sandra S.} and Karin Buckton and McIntyre, {Margaret A.} and Adams, {David J.} and Lewis, {Alexander D.} and Scott, {Angela R.R.} and Smyth, {John F.}",
year = "1987",
month = "6",
day = "15",
doi = "10.1002/ijc.2910390607",
language = "English",
volume = "39",
pages = "695--702",
journal = "International Journal of Cancer",
issn = "0020-7136",
publisher = "Wiley",
number = "6",

}

Wolf, CR, Hayward, IP, Lawrie, SS, Buckton, K, McIntyre, MA, Adams, DJ, Lewis, AD, Scott, ARR & Smyth, JF 1987, 'Cellular heterogeneity and drug resistance in two ovarian adenocarcinoma cell lines derived from a single patient', International Journal of Cancer, vol. 39, no. 6, pp. 695-702. https://doi.org/10.1002/ijc.2910390607

Cellular heterogeneity and drug resistance in two ovarian adenocarcinoma cell lines derived from a single patient. / Wolf, C. Roland; Hayward, Ian P.; Lawrie, Sandra S.; Buckton, Karin; McIntyre, Margaret A.; Adams, David J.; Lewis, Alexander D.; Scott, Angela R.R.; Smyth, John F.

In: International Journal of Cancer, Vol. 39, No. 6, 15.06.1987, p. 695-702.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Cellular heterogeneity and drug resistance in two ovarian adenocarcinoma cell lines derived from a single patient

AU - Wolf, C. Roland

AU - Hayward, Ian P.

AU - Lawrie, Sandra S.

AU - Buckton, Karin

AU - McIntyre, Margaret A.

AU - Adams, David J.

AU - Lewis, Alexander D.

AU - Scott, Angela R.R.

AU - Smyth, John F.

PY - 1987/6/15

Y1 - 1987/6/15

N2 - Two ovarian cell lines were derived from the ascites of a patient before and after the onset of resistance to chemotherapy involving cis‐platinum, chlorambucil and 5‐fluorouracil. Characterization of these lines shows them to have various features in common and some significant differences. Cytologically the lines cannot be distinguished and they both contain high concentrations of oestrogen receptor. However, they do differ with respect to their growth characteristics, karyotype, glutathione content and sensitivity to cis‐platinum. The karyotypes of the 2 lines show several marker chromosomes in common but the resistant line contained a chromosome 8 and a 17 which were absent from the earlier sensitive line. This suggests a clonal origin with subsequent divergence to a heterogeneous population.

AB - Two ovarian cell lines were derived from the ascites of a patient before and after the onset of resistance to chemotherapy involving cis‐platinum, chlorambucil and 5‐fluorouracil. Characterization of these lines shows them to have various features in common and some significant differences. Cytologically the lines cannot be distinguished and they both contain high concentrations of oestrogen receptor. However, they do differ with respect to their growth characteristics, karyotype, glutathione content and sensitivity to cis‐platinum. The karyotypes of the 2 lines show several marker chromosomes in common but the resistant line contained a chromosome 8 and a 17 which were absent from the earlier sensitive line. This suggests a clonal origin with subsequent divergence to a heterogeneous population.

UR - http://www.scopus.com/inward/record.url?scp=0023218482&partnerID=8YFLogxK

U2 - 10.1002/ijc.2910390607

DO - 10.1002/ijc.2910390607

M3 - Article

C2 - 3583449

AN - SCOPUS:0023218482

VL - 39

SP - 695

EP - 702

JO - International Journal of Cancer

JF - International Journal of Cancer

SN - 0020-7136

IS - 6

ER -